Comparison of First and Second Wave Cohorts of Multisystem Inflammatory Disease Syndrome IN Children

Ashraf S Harahsheh1,2, Matthew P Sharron2,3, James E Bost2,4

  • 1From the Division of Cardiology, Children's National Hospital, Washington, DC.

Insights

The second wave of pediatric Multisystem Inflammatory Syndrome in Children (MIS-C) patients were older and more severely ill, requiring more advanced support. However, both MIS-C waves showed similar outcomes regarding cardiac issues and hospital stay duration.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Cardiology

Background:

  • Multisystem Inflammatory Syndrome in Children (MIS-C) emerged during the COVID-19 pandemic.
  • Understanding the evolution of MIS-C clinical presentation and severity is crucial.

Purpose of the Study:

  • To compare clinical characteristics and outcomes between the first and second waves of MIS-C patients.
  • To identify changes in disease severity and patient demographics over time.

Main Methods:

  • Retrospective cohort study comparing two distinct time periods of MIS-C cases.
  • Analysis of patient demographics, clinical presentation, laboratory values, and treatment requirements.
  • Assessment of cardiac involvement, including coronary artery abnormalities and systolic dysfunction.

Main Results:

  • The second MIS-C cohort was older and presented with increased respiratory symptoms and cardiac biomarkers (troponin, N-terminal BNP).
  • Second wave patients more frequently required advanced respiratory and inotropic support.
  • Despite increased severity, both cohorts exhibited similar rates of coronary artery abnormalities, systolic dysfunction, and length of stay.

Conclusions:

  • While the second wave of MIS-C indicated increased illness severity and need for advanced support, long-term cardiac sequelae and hospitalization duration remained comparable.
  • This suggests potential shifts in MIS-C pathophysiology or host response over successive pandemic waves.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
445
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
561
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
112
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.3K